Price of arthritis drug jumps to $10,000 — 52x original price

In 2008, a box of 30 anti-inflammatory rectal suppositories that treats arthritis, called Indocin, had a price tag of $198. As of Oct. 1, the price of that same box was 52 times higher, totaling $10,350.

Why it matters: As federal lawmakers continue to waver on drug price reforms, Indocin is another example of how nothing prevents drug companies from hiking prices at will and selling them within a broken supply chain.

We are primarily funded by readers. Please subscribe and donate to support us!

Driving the news: Indocin has changed ownership multiple times over the years, and the companies involved have controversial histories.

  • Iroko Pharmaceuticals, the original owner of Indocin suppositories, consistently raised the drug’s price.
  • Indocin’s list price (what uninsured patients would pay) was $198 for 30 suppositories in 2008. Iroko raised it to $2,550 by January 2018 after more than a dozen separate increases, according to Elsevier’s Gold Standard Drug Database.


Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.